Reply to: “Understanding the Contribution of Anti-EGFR Reinduction to Overall Survival in TRIPLETE Study” and “TRIPLETE But Incomplete? Accounting for Post-Progression Therapy When Interpreting ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...